All lobbying filings

RED+BLUE STRATEGIES

RED+BLUE STRATEGIES filed a Q4 report for GENEDX, LLC on January 20, 2026, reporting $80,000 in lobbying income.

Lobbying for GENEDX, LLC · Health Care Diagnostics

All filings by RED+BLUE STRATEGIES · Everything GENEDX, LLC has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide.

Medicare/Medicaid

Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage.

Bills named in this filing 1

H.R. 4709
Newborn Screening Saves Lives Reauthorization Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.